|
|
$1 million in cash winnings and in-kind services draws worldwide interest
DETROIT, /PRNewswire-USNewswire/ — The Accelerate Michigan Innovation Competition, an international business competition designed to highlight Michigan as a robust and vibrant venue for innovation and business opportunity announced today that it has chosen its 50 company semi-finalists. These semi-finalists will compete for more than $1 million in cash winnings and in-kind awards of services, staffing and software.
The Accelerate Michigan Innovation Competition received nearly 600
Continue reading: Accelerate Michigan Innovation Competition Announces 50 Companies as Semi-Finalists
ANN ARBOR, MI–(Marketwire – November 8, 2010) - Fifty eight Michigan companies have been awarded federal tax credits or grants under the Qualifying Therapeutic Discovery Project Program. The initiative was created to promote research and development of products and therapies with promise to significantly advance healthcare in the country.
MichBio, the trade association driving biosciences industry growth in the state, announced that the 58 companies statewide received $18,374,696 million from the program, which was created as
Continue reading: Michigan Biosciences Companies Receive $18 Million in Federal Grants
Collaboration Expected to Generate High-Paying Jobs in Michigan
ANN ARBOR, Mich. and GRAND RAPIDS, Mich., Oct 26, 2010 (GlobeNewswire via COMTEX) — Aastrom Biosciences, Inc. /quotes/comstock/15*!astm/quotes/nls/astm (ASTM 1.84, +0.06, +3.37%) , a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, and ATEK Medical, a leading medical device manufacturer, today announced the formation of a new strategic partnership in which ATEK Medical will supply key components and technology for use
Continue reading: Aastrom and ATEK Medical Form Strategic Manufacturing and Development Partnership
ANN ARBOR, Mich., Oct. 25 /PRNewswire/ — Adeona Pharmaceuticals, Inc., (Amex: AEN) announced today that its Chief Executive Officer, James S. Kuo, M.D., M.B.A., will provide the keynote address at the Emerging Biosciences Showcase during the 2010 MichBio Expo & Conference.
The 2010 MichBio Expo & Conference will take place at the Ann Arbor Marriott Ypsilanti at Eagle Crest on October 26 and 27. The event is Michigan’s premiere event for the biosciences industry and brings
Continue reading: Adeona CEO to Provide Keynote Address at 2010 MichBio Expo
ANN ARBOR, Mich. – (BUSINESS WIRE) – NanoBio Corporation today announced that company founder and chief executive officer James R. Baker, Jr. MD, will meet with renown scientists at the 6th Annual Grand Challenges in Global Health (GCGH) Meeting, taking place from Oct. 25-27 in Seattle, Wash., to present data illustrating the potential of the company’s nanoemulsion-based needle-free intranasal vaccine platform to alleviate the suffering caused by infectious diseases in developing countries.
GCGH supports research
Continue reading: NanoBio CEO to Present at the 6th Annual Grand Challenges in Global Health Meeting
ANN ARBOR, Mich., Oct. 25, 2010 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that Ronald Cresswell, Ph.D., Hon. D.Sc., FRSE, has joined the company’s board of directors. Dr. Cresswell is the former senior vice president and chief scientific officer of Warner-Lambert and has served on the board of directors of Esperion Therapeutics, Inc., Allergan, Inc., Curagen Corporation, and
Continue reading: Ronald Cresswell Joins Aastrom Board of Directors
|
|
Loading ...
Ann Arbor, MI